Corbus Pharmaceuticals Holdings, Inc.CRBPNASDAQ
LOADING
|||
Net Income Contraction
Above historical average, strong compound growth.
Left:
||||
Total earnings after all expenses, taxes, and interest
Latest
$-40.21M
↑ 17% above average
Average (9y)
$-48.59M
Historical baseline
Range
High:$-8.85M
Low:$-111.27M
CAGR
+18.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-40.21M | +9.9% |
| 2023 | $-44.60M | +20.1% |
| 2022 | $-55.83M | -22.6% |
| 2021 | $-45.55M | +59.1% |
| 2020 | $-111.27M | -55.7% |
| 2019 | $-71.45M | -28.3% |
| 2018 | $-55.67M | -71.7% |
| 2017 | $-32.42M | -62.1% |
| 2016 | $-20.00M | -126.0% |
| 2015 | $-8.85M | - |